Secondary Inflammatory Disorders After Radiotherapy

Clicks: 1
ID: 333336
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #235 of 235 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 235 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Radiotherapy (RT) is widely used in cutaneous oncology and increasingly combined with immunotherapy and targeted therapies. Beyond DNA damage, RT modulates the cutaneous immune microenvironment, contributing to both antitumour effects and inflammatory skin toxicities. While radiodermatitis is the most common reaction, RT may induce a broad spectrum of dermatoses, including postirradiation pseudosclerodermatous panniculitis, radiation-induced isotopic response, eosinophilic polymorphic pruritic eruption, and atypical vascular proliferations. Combined therapies further expand toxicity profiles. Recognition of this evolving spectrum is crucial for accurate diagnosis, timely management, and improved multidisciplinary care.
Reference Key
openalex_W7223184305 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ane Carrera‐Gabilondo, Isabel Jorques Belda, Marta Moreno Jiménez, Agustín España
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag430
URL
https://doi.org/10.1093/ced/llag430
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.